Table 1
Study characteristics.
| Study groups | Average Age (in years) | Gender | Site | Staging | |||||
|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Gingivo-buccal sulcus | Alveolus | Tongue | Buccal mucosa | III | IV | ||
| OSCC with lymph node metastasis | 52.92 | 16 | 9 | 8 | 10 | 3 | 4 | 18 | 7 |
| OSCC without lymph node metastasis | 53.88 | 17 | 8 | 9 | 11 | 2 | 3 | 19 | 6 |

Figure 1
NE immunostaining in OSCC. A- No NE immuno-staining (400 × magnification), B- Mild (1–25%) NE immuno-staining (400 × magnification), C- Intense (>50%) NE immuno-staining (400 × magnification).